Skip to main content
Clinical Trials/NCT02175134
NCT02175134TerminatedNot Applicable

IFN-gamma-releasing Assay Based Approach in Patients With Suspected Tuberculous Peritonitis

Asan Medical Center2 sites in 1 country2 target enrollmentStarted: July 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
2
Locations
2
Primary Endpoint
the frequency of laparoscopic biopsy

Study Overview

Brief Summary

The diagnosis of tuberculous peritonitis (TBP) is still challenging, and largely dependent on invasive procedures such as laparoscopy. A recently developed RD-1 gene-based assay for diagnosing TBP shows has given promising results. The investigators thus created a 2-step algorithm using the Blood/Ascites ELISPOT assays and adenosine deaminase (ADA) in ascites for differentiation of TBP from other diagnoses (Blood ELISPOT ≥6 spots or ADA ≥ 21 U/L' as a rule-out test and 'Ascites/Blood ratio ≥3' as a rule-in test). This study is the randomized controlled trial on whether this 2-step algorithm-based approach can reduce the laparoscopic biopsy for the diagnosis of TBP in patients with suspected TBP.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
16 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • all patients with suspected tuberculous peritonitis
  • age 16 or more
  • formal informed consent

Exclusion Criteria

  • not specified

Arms & Interventions

conventional diagnostic flow arm

No Intervention

Perform the laparoscopic biopsy as a discretion of attending physician's decision

two-step algorithm-based approach

Experimental

Perform the laparoscopic biopsy as a discretion of attending physician's decision, but if the below conditions are met, do not perform the laparoscopic biopsy.

  1. Blood ELISPOT >= 6 spots or ascites adenosine deaminase > 20 IU/L, and
  2. Ascites ELISPOT/Blood ELISPOT rato > 3

Intervention: Blood and Ascites ELISPOT (Other)

Outcomes

Primary Outcomes

the frequency of laparoscopic biopsy

Time Frame: 1 week after the enrollment

Secondary Outcomes

  • the frequency of correct or wrong diagnosis(6 months after the enrollment)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Sung-Han Kim

Associate Professor

Asan Medical Center

Study Sites (2)

Loading locations...

Similar Trials